Shu Sun

Title: The Innovations of Shu Sun

Introduction

Shu Sun is an accomplished inventor based in Farum, Denmark. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Shu Sun continues to push the boundaries of scientific research and development.

Latest Patents

Shu Sun's latest patents include the "Type XXIII collagen assay" and "Immunoassay for collagen type VI." The Type XXIII collagen assay provides monoclonal antibodies that target collagen type XXIII, along with immunoassays and kits for detecting and quantifying the epitope. This invention also offers a method for identifying and monitoring subjects with inflammatory bowel disease. The immunoassay for collagen type VI presents an immunological binding partner reactive with a C-terminal epitope of the C5 domain of the α3 chain of collagen Type 6. It includes a method of immunoassay for detecting and quantifying the C-terminal epitope, as well as methods for investigating the rate of formation of extracellular matrix and identifying subjects suitable for treatment with an insulin sensitizer.

Career Highlights

Shu Sun is currently associated with Nordic Bioscience A/S, where he applies his expertise in immunology to develop groundbreaking solutions. His work has been instrumental in advancing the understanding of collagen-related diseases and their treatment.

Collaborations

Shu Sun collaborates with notable colleagues, including Anders Nedergaard and Jannie Marie Sand. Their combined efforts contribute to the innovative research environment at Nordic Bioscience A/S.

Conclusion

Shu Sun's contributions to the field of immunology through his patents and collaborations highlight his role as a leading inventor. His work continues to impact the scientific community and improve patient outcomes.